Clinical trials: Abnormal Pap Smear
Colposcopy, Biopsy
Adequacy and Efficacy of the e2TM Cervical Cell Collector Compared to Standard Spatula/CytoBrush Technique.
A clinical study to determine the adequacy and efficacy of the InPath e2TM Collector compared to the FDA-approved spatula/cytobrush when used as the cell collection device in screening for cervical cancer.
- Trial name
- NCT00474968
- Testing
- e2 Cell Collector [SoftPAP(R)], Spatula/Brush
- Where
- 7 sites in United States
- Volunteers
- 737 people
- Sponsor
- CytoCore, Inc.